2',3',5'-Trideoxyuridine-5'-methylphosphonate, [8], was synthesized from ddU. The 5',6' carbon-carbon bond was formed by condensing the..I'-aldehyde of ddU and a Wittig reagent. The bindiNg interaction of the diphosphate derivative [10] of the phosphonate [8] with HIV-1 reverse transcriptase (RT) was studied using methods based primarily on fluorescence spectroscopy. From the quenching of intrinsic tryptophan fluorescence of RT during its titration against [10], a dissociation constant of 24J..lM was calculated at 25°C. In the presence of a DNA/DNA template/primer of defined sequence and RT, [10] and a fluorescent derivative of ddTTP competed for binding to RT without incorporation of ddU-5'-methylphosphonate. In the presence of a 0.5 mM concentration of [10], the RT activity measured with Poly(rA)/(dT)15 and [3H] dTTP was lowered to 65%. All our observations are consistent with suppression of the catalysis of bond formation between the OH at the primer 3'end and o-P of [10] after formation of the complex between RT, template/primer and [10].
Introduction
Most of the nucleoside analogues active against human immunodeficiency virus (HIV) have been shown to interact with the polymerase binding site of HIV reverse transcriptase (RT) following their intracellular activation to the corresponding 5'-triphosphate derivatives. The stepwise phosphorylation process involves at least three cellular enzymaticactivities: nucleosidekinase (or 5'-nucleotidase), nucleotide kinase and nucleoside diphosphate kinase.
The substrate (or inhibitory) properties of these analogues with respect to the above cellular enzymes vary widely and depend primarily on their structure. However, the most critical step is generally the first phosphorylation of the nucleosideanaloguescatalysedby nucleosidekinases, as in the case of dT (Waqar et et., 1984) , and ddC (Cooney et a/. , 1986) .A notable exceptionis AZT which is efficiently converted to 5'-AZTMP, this product being an inhibitor of dTMP kinase which is needed for further phosphorylation (Furman et a/., 1986 ; Balzarini et et., 1989) . In the case of 2',3'-dideoxyuridine, the importance of the cellular kinases is even more critical since this compound is inactive against HIV, although its 5'-triphosphate derivative is an efficient chain terminator inhibitor of RT (Hao et el., 1990) . We have previously explored several ways of increasing the efficiency of ddU or its analogues against HIV by intracellular delivery of phosphate derivativesthrough Iiposome encapsulation (Zelphati et a/., 1993) or the use of corresponding phosphodi-or triesters Perigaud et a/., 1993; Puech et st., 1993) . The present work is another attempt to 'bypass' the first enzymatic phosphorylation step of ddU by preparing an isosteric analogue insensitive to nucleotide hydrolase while hopefully retaining substrate properties with respect to uridylate kinase or to other phosphorylating enzymes. In this respect, 2',3',5'-trideoxyuridine-5'-methylphosphonic acid, 8, was expected to have the required stereochemistry for further phosphorylation. Although other 2',3',5'-trideoxynucleoside-5-methylphosphonic acids have been previously prepared (Secrist et si., 1992; Freeman et el., 1992) ,8 is not known. We therefore decided to synthesize this compound, to evaluate its activity against HIV, and to study the interaction of its diphosphate derivative with RT.
Results

Chemistry
Starting from 2',3'-dideoxyuridine (ddU), we explored three different methods to create the 5',6' carbon-carbon bond of the target molecule 8.
First, we tried a substitution reaction at the 5'-carbon of ddU by attack with a carbanion generated from a o C NH methylphosphonate stabilized by the adjacent phosphonic ester function. This strategy involved the iodide 2 ( Fig.1 ) as substrate and was analogous to the approach used in the thymidine series, yielding both substitution and elimination products probably via a 2,5'-anhydro intermediate (Ray and Jaxa-Chamiec 1990) . From the iodide 2 and the carbanion of dimethyl methylphosphonate, only the Nmethylated product 3 was obtained in good yield, without displacement of the iodine atom and as a mixture of the corresponding a and~anomers. This implies a charge transfer to N-3, methyl exchange with dimethyl methylphosphonate and at least partial anomerization. That the reaction observed was different from that of corresponding thymidine derivatives may be due to an unfavourable conformation of the dideoxyfuranose ring preventing the formation of the 2,5'-anhydro activating intermediate. We then investigated the possibility of forming the 5',6' carbon-earbon double bond from the 5'-aldehyde derived from ddU. The Emmons condensation of the stabilized carbanion of tetraethyl methanediphosphonate (Kosolapoff, 1953) with the aldehyde 4 obtained by Moffatt oxidation (Harada and Orgel 1990) of ddU led to a mixture of several products, each obtained in low yields. These compounds were not studied in detail, but we found using NMR spectrometry that they were different from the expected olefinic product and that partial ester cleavage had occurred (Kosolapoff, 1953) which may be detrimental, after hydrolysis, to the acid-sensitive 2',3'-dideoxyribofuranose ring (York, 1981) .
IN0
According to data in the recent literature, the Wittig reaction has been successfully used to introduce a carbon-earbon exo-double bond to the furanose ring l:X=OPh l:X=OCHzPh 8: X =OH 9: X= ONa ,-oJ (Almer et al., 1991; Samano and Robins, 1991; Freeman et et., 1992; Secrist et al., 1992) . We therefore condensed diphenyl triphenylphosphoranylidene methylphosphonate with 2',3'-dideoxy-5'-oxouridine, 4, prepared in situ. As shown by NMR spectroscopy, the reaction yielded the E olefin 5. The selective hydrogenation of the 5',6' bond of 5 catalysed by palladium gave the phosphonate 6 in good yield. Two methods are available to hydrolyse the diphenyl phosphonate functions of such nucleotide analogues Secrist et al., 1992) . Using the transesterification method, the dibenzyl ester 7 was prepared and then catalytically hydrogenated to 2',3',5'-trideoxyuridine-5'-methylphosphonic acid, 8. The free acid was transformed with Dowex 50WX2 into the sodium salt 9. The diphosphate derivative 10 was synthesized by converting 8 into its tri-n-butylammonium form which was then activated in the presence of 1,1-carbonyldiimidazole before the addition of tri-n-butylammonium pyrophosphate. The tributylammonium salt was converted to the sodium salt 10, and the structure of 10 was characterized by 1 Hand 32p NMR spectroscopies, and mass spectrometry.
Antiviral evaluation
The phosphonates 5, 6, 7, and 9 were tested for their in vitro inhibitory effects on the replication of a number of DNA viruses (I.e. human cytomegalovirus, herpex simplex virus type 1 and type 2, and vaccinia virus) and RNA viruses (parainfluenza virus type III, respiratory syncytial virus, Sindbis virus, Coxsackie virus B3, and polio virus-f) in three cell systems (MRC-5, Vero and KB cells). None of these compounds showed marked antiviral effects or 2 ', 3', detectable alteration of host cell morphology at the highest concentration tested (generally 1J.v>-4 M). When evalu-... ated in two anti-HIV assays, none ofJ!le tested compounds showed significant antiviral effect at a concentration lower by a factor of more than 10 than the minimal concentration causing a detectable alteration of MT-4 and CEM host cell viability (=::; 10-5 M). 
Fluorescence experiments and enzymology
The inactivity of the analogue 9 against HIV in cell culture could be due to several factors, including its weak SUbstrate properties for cellular kinases or the low inhibitory activity of the corresponding diphosphate against HIV reverse transcriptase. In order to examine this second possibility, we investigated the interaction of 10 with the p66. p51 heterodimeric form of HIV-1 RT (Muller et el., 1989) using fluorescence spectrometry and enzymatic assay.
HIV-1 RT exhibits a characteristic intrinsic tryptophan fluorescence with a maximal emission at 338 nm due to the 37 tryptophan residues of the enzyme molecule (Divita et al., 1993) . The binding of 10 to RT induced a 25% quenching of intrinsic fluorescence. Plotting of the fluorescence intensity versus the ligand concentration allowed the dissociation constant of the complex between compound 10 and the enzyme to be calculated (Fig. 2) . The value obtained (24 IlM) is 3-to 5-fold larger than the dissociation constants of natural 2'-deoxynucleoside triphosphates (Kati et al., 1992) . The dissociation constant of the complex that is formed between 10 and the enzyme saturated with template/primer 11 has been determined and found to be 29 IlM under the same conditions. The affinity of 10 for the enzyme is therefore not very different from the affinities of natural substrates in the absence or in the presence of template/primer (Painter et al.,1991) .
To investigate further the interaction of 10 with RT in the presence of template/primer, compound 10 and the fluorescent analogue of dideoxythymidine triphosphate (12) were allowed to compete for incorporation into the 36/18 DNA/DNA template/primer hybrid (11) in the presence of RT. An increase in the concentration of 10 up to 0.5 mM, with the concentrations of 11 and 12 fixed at 100 and 150 nM respectively, apparently did not change the rate of incorporation of 12 at the 3'-end of the primer. A very slight effect on the rate of incorporation was detected only when the concentration of 10 was above 0.5 mM ( Fig. 4 ). Thus the existence of a competition for RT between 10 and 12 is observed only when a very large proportion of 10 is used. This competition between 10 and 12 may be due to two different phenomena: competitive inhibition at the substrate binding site of RT either with the incorporation of 12 alone into the hybrid or with the incorporation of both 10 and 12. In the first situation, the final value of the fluorescence iritensity is expected to be independent of the concentration of 10, whereas in the second it is expected to depend markedly on this concentration (Muller et al., Discussion Fig. 4 . Competition experiments between 10 and the fluorescent analogue 12 (150 nM), in the presence of the template/primer hybrid 11 (100nM) and RT (500nM) at 25°C. The concentration of 10 was increased from 0 to 0.5 mM without any apparent effect (a), while a slight effect waS observed when the concentration of 10 was increased to 0.6 mM (b). The buffer was the same as in experiments involving intrinsic RT fluorescence.
Materials and Experimental procedures: chemistry
Melting points were determined in open capillary tubes on a Gallenkamp MFB-595-01 0 M apparatus (Gallenkamp, Loughborough, UK) and are uncorrected. The UV absorption spectra were recorded on an Uvikon 810 (KONTRON Instruments SA, St Quentin Yuelines, France) spectrophotometer. 1H_ NMR spectra were run at ambient temperature in DMSO-d s (unless otherwise indicated) with a Bruker AC 250 spectrometer (Bruker Spectrospin SA, Wissembourg, France). Chemical shifts are given in ppm, DMSO-d s being set at 2.49 ppm as reference. Deuterium exchange and decoupling experiments were performed in order to confirm proton assignements. 31 p, NMR spectra were recorded on the same apparatus with that it is not a substrate of this enzyme, or a very weak one, under the conditions used. It is therefore likely that 10 binds the enzyme-template/primer complex competitively with other nucleoside triphosphates, and that there is inhibition of the nucleophilic substitution at o-P of compound 10 by the terminal 3'-hydroxyl group of the primer. This is similar to the properties of the closely related analogue 3'-azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate, which has been shown to be a very poor substrate of RT from steady-state kinetic experiments (Freeman et a/., 1992) . Reasons for the suppression of incorporation upon replacement of the oxygen atom by the 6'-CH 2 group may be suggested by consideration of the recently published hypothetical mechanism for the polymerase reaction (Steitz, 1993) . This mechanism is based on the existence of two essential magnesium ions in the active site which strictly control the stereochemistry of the substitution of pyrophosphate at a-P by the alkoxide anion from the 3'-OH group. It is theref?re possible that the changes in bond lengths, bond angles and polarities induced by the introduction of the 6'methylene group are detrimental to the stabilization of the postulated pentacovalent transition state at the a-phosphate. . The results of competition experiments, together with intrinsic fluorescence measurements showing that 10 displays a lower affinity for RT than normal nucleoside triphosphates with no apparent incorporation in the presence of template/primer, suggest that 10 is not a substrate of RT, or only a very poor one. Finally, the inhibition of RT by 10 was measured in steady-state kinetics in the presence of the hornopolymeric template/primer Poly(rA)/(dT)1s and (3H)dTIP at 37°C. At constant concentrations of template/primer (4.7IJ.M), substrate (20I1M) and enzyme (4 nM), and variable concentrations of 10 (0 to 1 mM), the incorporation of dTMP versus time was linear for at least 10 min. In these conditions, the enzymatic activity was reduced to about 35% at an inhibitor concentration of 0.5 mM and almost completely suppressed at a concentration of 1 mM (50% inhibitory concentration: ICso -0.37 mM) ( Fig.5) . At 25°C and in the presence of 0.2 mM10, the activity was lowered to 60% of its value in the absence of 10.
Experiments reported in this paper indicate that the phosphonate 9 does not inhibit the in vitro replication of HIV. Such inactivity could stem from several causes, including the lack of substrate properties for cellular kinases, the intracellular instability of 8 or its metabolites, and/or the inability of the diphosphorylated derivative 10 to inhibit HIV RT. From our experiments, it can be concluded that 10 displays very weak inhibitory effects on RT and also 2',3',5'-Trideoxyuridine-5'-methylphosphate study with HIV RT 225 H 3P0 4 as external reference. FAB mass spectra were recorded in the positive or negative ion mode on a JEOL DX 300 mass spectrometer operating with a JMA-DA 5000 mass data system (JEOL Europe SA, Croissy sur Seine, France). The matrix was 3-nitrobenzyl alcohol or a mixture (50:50, v/v) of glycerol and thioglycerol. Elemental analyses were carried out by the Service de Microanalyses du CNRS, Division de Vernaison (France).Thin layer chromatography was performed on pre-coated aluminium sheets of silica gel, Kieselgel 60 (Merck, Art.5554; Merck-Clevenot SA, Nogent sur Marne, France); visualization of products was accomplished by UV absorbance followed by charring with 10% ethanolic sulfuric acid and heating. Column chromatography was carried out on silica gel, Kieselgel 60 (Merck, Art. 9385) at atmospheric pressure, or on Dowex ion exchanger 50WX2, 200-400 mesh (Fluka, Art. 44465; Fluka S.a.r.i., St Quentin Fallavier, France), or on Sephadex DEAE A-25-120 (Fluka, Art. 84956).
2',3',5'-Trideoxy-5'-iodouridine (Fig. 1, structure 2) Methyltriphenoxyphosphonium iodide (4.28 g, 9.46 mmol) was added to a solution of 2',3'-dideoxyuridine (1 g, 4.71 mmol) in anhydrous DMF (19 mI). After stirring the mixture under argon for 2.5 h at room temperature, anhydrous methanol (680 Ill) was added and the stirring continued for 10 min. Most of the DMF was removed under vacuum, ants the organic material extracted with dichloromethane. After~shing with water saturated with sodium thiosulfate, the organic layer was dried and the solvent evaporated. Purification of the solid residue by crystallization in chloroform/cyclohexane gave 1.39g (91%) of the title compound: mp: 174°C (dec.); UV (95% EtOH) Amax 258 nm (E, 8300), Amin , 33.56 ; H, 3.44; N, 8.70. Found: C, 33.58; H, 3.33; N, 8.71 . '3-methyl-2:3',5'-trideoxy-5'-iodouridine (Fig. 1, structure 3) A solution of butyl lithium 1.6 M in hexane (870 Ill, 1.39 mmol) was added dropwise to dimethyl methylphosphonate (170111, 1.55 mmol) at -78°C, under argon. After the addition of 2',3',5'trideoxy-5'-iodouridine (100 mg, 310 urnol) in anhydrous THF (4 ml), the mixture was stirred at room temperature for 48 h, then diluted with chloroform (10 ml) and extracted with a solution of 260 mg of sodium bicarbonate in 20 ml of water. After washing with water, the organic layer was dried and the solvent evaporated. The residue was chromatographed on silica gel [eluent: methanol(O to 2%)/dichloromethane]. The product was obtained as an oil (87 mg) containing 74% of the l3-anomer, and 26% of the a-anomer based on the NMR spectrum: UV (95% EtOH) A ma x 257nm; Amin 230 nm; 1HNMR l3-anomer: 1) 7.71 (1H, d, H-6,J6-s = 8.1 Hz), 6.07 (1H, dd, H-1', J1'-2'= 6.7 Hz, J 1'-2"= 4.4 HZ), 5. 76 (1H .d, H-5), 4.06 (1H, m, H-4'), 3.56-3.43 (2H, rn, H-5' and H-5") , 2.39-2.28 (1H, rn, H-2'), 2.19-1.98 (2H, rn, H-3' andH-2"), 1.79-1.68 (1H, m, H-3"); a-anomer: 7.40 (1H, d, H-6), 6.53 (1H, dd, H-1', J 1'-2'= 9.6Hz, J1'-2"= 3.8 Hz), 5.77 (1H, d, H-5), 4.80 (1H, m, H-4'), 3.56-3.43 (2H, m, H-5' and H-5"), 3.15 (2H, rn, H-2' and H-3'), 3.10 (2H, m, H-2" and H-3") . FAB>O mass spectrum on the mixture m/z 673 (2M+Ht, 337 (M+Ht, 211 (st, 3', 5', (Fig. 1, structure 5 ) Diphenyl triphenylphosphoranylidene methylphosphonate was prepared as previously described (Jones et sl., 1968) and characterized as a solid (mp= 146°C) by 1HNMR, FAB mass spectrometry [m/z 509 (M+Htl and elemental analysis.
Mixture of anomeric forms of N
Trifluoroacetic acid (1801-11, 2.35 mmol) was added to a stirred mixture of ddU (1 g, 4.7 mmol), dicyclohexylcarbodiimide (2.91 g, 14.1 mmol) and anhydrous pyridine (380 Ill) in DMSO (15.7 ml) at room temperature. After 12 h, the solid was filtered, and diphenyl triphenylphosphoranylidene methylphosphonate (4.18g, 8.23 mmol) was added. The stirring was continued at room temperature for 24 h, and then water (1OOml) was added. After extraction with ethyl acetate (3x100 ml), drying and evaporation, the excess of Wittig reagent was removed by crystallization. Evaporation of the solvent gave 6.8 g of residue, which was chromatographed on silica gel [eluent: methanol(Q-10%)/ dichloromethane] to give a fraction of 5 (1.24 g) that was sufficiently pure to be used in the next step, and another fraction of pure 5 as a glassy solid after lyophilization (500 mg): 1HNMR 1) 11.32 (1H, s, NH-3), 7.47 (1H, d, H-6, J6-s= 8.1 Hz), 7.43-7.19 (2m, 1OH, 2Ph), 7.12-6.94 (1H, m, H-6'), 6.36-6.20 (1H, dd, H-5', J S'-6'= 17.4 Hz, J S'--4'= 5.7 Hz), 6.04 (1H, dd, H-1', J 1'-2'= 7.0 Hz, J 1'-2"= 3.4 Hz), 5.56 (1H, d, H-5), 4.60 (1H, m, H-4'), 2.40-1.34 (4H, 4m, H-2', H-2", H-3' and H-3"); 31pNMR 1) 12.58; FAB>O mass spectrum m/z 441 (M+H)+, 329 (st, 113 (BH 2t" Anal.: Calc. (C 22H21 N 2 OsP): C, 60.00 ; H, 4.81; N, 6.36; P, 7.04. Found: C, 59.75; H, 5.17 ; N, 6.17; P, 7.10.
1-(2', 3',5',6'-tetradeoxy-6'-diphenoxyphosphono-f3-Derythro-hexofuranosyl)uracil (Fig. 1, structure 6) A solution of compound 5 in ethanol 95 (50 ml/mmol of 5) containing 10% palladium on activated carbon (143 mg/mmol of 5) was hydrogenated for 6.5 h at atmospheric pressure. Removal of the catalyst by filtration, evaporation of the solvent and chromatography of the residue on silica gel [eluent: methanol(Q-20%)/ethyl acetate] gave 6 as a glass after lyophilization (80%): 1HNMR 1) 11.27 (1H, s, NH-3), 7.56 (1H, d, H-6, J6-s= 8.1 HZ), 7.42-7.36 and 7.24-7.17 (10H, 2m, 2Ph), 5.96 (1H, dd, H-1', J 1'-2'= 7.5 Hz, J1'-2"= 3.7 Hz), 5.58 (1H, d, H-5), 4.03-3.97 (1H, m, H-4'), 2.3Q-2.15 (3H, rn, H-2', H-6' and H-6"), 2.07-1.92 (4H, m, H-2", H-3', H-5' and H-5"), 1.76-1.64 (1H, m, H-3"); 31pNMR 1) 27.32; FAB>Omass spectrum m/z 443 (M+Ht, 331 (st. Anal.: Calc. (C22H23N20sP): C, 59.72; H, 5.24; N, 6.33; P, 7.00. Found: C, 60.09; H, 5.68; N, 6.22; P, 6.82. 3', 5', (Fig. 1, Structure 7) Benzyl alcohol (30 ml) was_slowly added at room temperature to a stirred solution of sodium hydride (975 mg, 50% in oil, 20.3 mmol) in dry diethyl ether (27 ml). After h}Ld[9gen evolution, the ether was evaporated. The resulting residue was added dropwise to a stirred solution of 6 (1.14 g, 2.57 mmol) in benzyl alcohol (40 ml). After 12 h at room temperature, TLC analysis indicated that the reaction was complete. Ethyl acetate (100 ml) along with dry ice was added and the mixture was washed with water (70 ml). The organic layer was dried, the solvent evaporated and the residue purified by chromatography on silica gel [eluent: methanol(O-4%)/dichloromethane], yielding the product (1.12 g, 93%) as a glass after lyophilization: 1 HNMR 1) 11.27 (1H, s, 7.49 (1H, d, 7.35 (1OH, m, 2Ph), 5.91 (1H, dd, Hz, J1'-2"= 3.7 Hz), 5.56 (1H, d, m, 2CH 2Ph), 3.88 (1H, rn, , 2.20 (1H, rn, H~2'), 1. 94-1.47 (7H, m, H-2", H-3', H-3", H-5', H-5", H-6' and H-6") ; 31p NMR 1) 33.62; FAS>O mass spectrum m/z 493 (M+Nat, 471 (M + H]", 359 (st. Anal.: Calc. (C 2 4H2 7 N 2 0 eP+0.6 H 2 0 ): C, 59.97; H, 5.79; N, 5.83; P, 6.44. Found: C, 60.10; H, 6.13; N, 5.68; P, 3', 5', uracil disodium salt (Fig. 1, structure 9) Compound 7 (436 mg, 0.93 mmol) in anhydrous methanol (34 ml) containing 10% palladium on activated carbon (39 mg) was hydrogenated for 1 h at atmospheric pressure. Filtration of the catalyst and evaporation of the solvent yielded the acidic form (268 mg, 99%). The acid was chromatographed on a Dowex 50WX2 (Na" form) column; elution with water gave the disodium salt as a foam after lyophilization (277 mg, 90%): 1HNMR (DMSO-d e+D20) 1)7.56 (1H, d, H-6, J6-s= 8.0 Hz), 5.88 (1H, dd, H-1', J1'-2'= 7.1Hz, J 1'-2"= 3.2 Hz), 5.63 (1H, d, H-5), 3.91 (1H, rn, H-4'), 2.2 (1H, m, H-2'), 1.9-1.2 (7H, m, H-2", H3', H-3", H-5', H-5", H-6' and H-6") ; 31p NMR (DMSO-d e+D2 0 ) 1) 20.94; FAS<O mass spectrum m/z 645 (2M-Nar, 623 3', 5', uracil sodium salt (Fi!:J.1, structure 10)
1
The pyridinium salt of 8 was prepared by stirring 9 (100 mg, 0.3 mmol) with Dowex 50WX2 (pyridinium form) in water (7 ml) for 4 h. After filtration, evaporation and coevaporation of the residue with anhydrous n-tributylamine (3x230 ).11), absolute ethanol and anhydrous toluene gave the n-tributylammonium salt of the phosphonate 8 (114 mg, 0.25 mmol). The latter was dissolved in 1,3-dimethyl-3,4,5,6-tetrahydropyrimidin-2(1H)-one (5.25 ml). 1,1'-Carbonyldiimidazole (318 mg, 1.96 mmol) was added, and the mixture was stirred for 1 h at room temperature under argon. Methanol was added (90 ).11, 2.22 mmol) and the stirring was continued for 2.25 h, then tributylammonium pyrophosphate (616 mg, 1.35 mmol) was added and the reaction mixture was stirred overnight. The reaction was stopped by the addition of cold water (44 ml) and the entire mixture was applied to a DEAE Sephadex A-25 column (2x30 cm) equilibrated in 1 mMtriethylammonium bicarbonate (TEAS). Two linear gradients of TEAS (200 rnl: 1 mMto 0.2 M,then 800 ml: 0.2 Mto 0.5 M) were successively used to elute the products. Further purification was carried out by TLC (3 migrations with isopropanol/ammonia/water: 11/7/2, v:v:v) and a second DEAE Sephadex A-25 chromatography with two successive linear gradients of TEAS (200 ml: 1 mMto 0.2 M, then 400 ml: 0.2 Mto 0.5 M). The fractions containing the product were combined, dried under vacuum, redissolved in water and lyophilized. The residue was redissolved in water and converted to the sodium salt by passage through a Dowex 50WX2 column (Na'forrn), The fractions con" taining the product were combined and lyophilized to give the sodium salt of 10 as a solid (36 mg, 28%): 1HNMR (0 2 0 ) 1)7.82 (1H, d, H-6, J6-s= 8.1 Hz), 6.10 (1H, dd, H-1', J 1'-2'= 7.1 Hz, J 1 '-2"= 3.0 Hz), 5.93 (1H ,d, H-5), 4.22 (1H, m, H-4'), 2.57-2.44 (1H, m, H-2'), 2. 77-1.69 (7H, m, H-2", H-3', H-3", H-5', H-5", H-6' and H-6") ; 31P-NMR (0 20) 1) 19.93 (1P, d, P-a., Ja-~= 25.9 Hz), -9.43 (1P, d, P-y, JIl--'f' 19.9 Hz), -22.0 to -22.45 (1P, dd, P-f3); FAS<O mass spectrum m/z 515 .
Materials and Experimental procedures: virology and enzymology
.
Antiviral evaluation
The broad antiviral assays on cell culture and the anti-HIV assays were performed by previously established procedures (Genu-Dellac at el., 1991a, b).
Enzymology and Fluorescence experiments
Oligonucleotides were obtained as already indicated (MOiler et aI., 1991) , and the fluorescent nucleotide analogue 12 was obtained from DuPont-New England Nuclear (Sad Homburg, Germany). Recombinant HIV-1 reverse Iranscriptase was expressed in E. coli and purified as described earlier (MOiler et al., 1989) . The expression systems and purification protocols allow the preparation of large quantities of the heterodimer in homogeneous form. Fluorescence experiments were performed with a SLM-Smart-8000 spectrofluorometer equipped with a PH-PC 9626 photomultiplier (SLM, colora, Lorch, WOrth, Germany). The spectral bandwidths were 2 and 8 nm for excitation and emission, respectively. Measurements were carried out at 25°C in a buffer containing 50 mMTris-HCI, pH 8, 10 mM MgCI 2 , 80 mM KCI, and 1 mM OTT, in a total volume of 0.8 ml.
All measurements were corrected for inner filter effects, volume variations, and buffer blank. In competition experiments, the template/primer 11 (100 nM) was allowed to equilibrate with saturating amounts of RT. The samples were excited at 500 nm and emission intensity was measured at 532 nm. The reaction was started by adding the fluorescent substrate 12 (150nM) and then variable amounts of 10. In intrinsic tryptophan fluorescence experiments, the excitation was performed at 295 nm in a quartz cuvette with a 5 mm optical path length. The emission intensity was measured at 340 nm. The concentration of RT (as the p66.p51 heterodimer) was 100 nM. The experiment was carried out in the absence or in the presence of the template/primer hybrid 11 (0.5 ).1M). The decrease of fluorescence intensity versus ligand concentration was automatically recorded, transferred to a personal computer and fitted using the program Grafit (Erithacus Software Ltd, London, UK) according to the following equation: where F, F max' and F min are the observed fluorescence intensity, the fluorescence intensity at the start of the titration, and the intensity at saturating concentration of the ligand, respectively. Eo is the total concentration of the enzyme, La the total concentration of ligand and K d the dissociation constant of the enzyme/ligand complex. The experiment was performed 3 times and the standard deviations were lower than 10% in all measurements.
2 ', 3', Steady-state kinetic experiments
The buffer used was the same as in the fluorescence experiments completed with BSA (0.5 mg mr"), The reaction mixture (0.1 ml) also contained 20 11M [3H] dTTP (0.25 Ci rnmor"), 4.7 11M
Poly(rA)/(dT)15 (Boehringer, base ratio: 1/1) and 10 (0 to 1 mM).
The reaction was started by addition of RT (4 nM). The reaction kinetics were followed for 10 min at 37"C and were stopped by addition of 2 ml of ice-cold 5% trichloroacetic acid. Acid insoluble materials were collected on nitrocellulose filters (Schleicher and Schuell, 0-3345 dassel, Germany), and the radioactivity retained on the filters was measured by scintillation counting.
